The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Medical Distribution
Realcan Pharmaceutical Price, Forecast, Insider, Ratings, Fundamentals & Signals
6.32% CNY2.85
America/New_York / 5 mai 2024 @ 22:35
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 3 614.80 mill |
| EPS: | -1.270 |
| P/E: | -2.24 |
| Earnings Date: | May 21, 2024 |
| SharesOutstanding: | 1 268.35 mill |
| Avg Daily Volume: | 27.88 mill |
| RATING 2024-04-30 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Strong Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -2.24 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.04x |
| Company: PE -2.24 | industry: PE 57.23 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY-0.911 (-131.98%) CNY-3.76 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 2.55 - 2.82 ( +/- 5.04%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY2.85 (6.32% ) |
| Volume | 27.24 mill |
| Avg. Vol. | 27.88 mill |
| % of Avg. Vol | 97.68 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 002589.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
002589.SZ
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institution worldwide. It sells drugs, vaccines, and medical devices. The company also provides medical logistics services; third-party logistics services; disinfection and sterilization; and lease, and hospital logistics services for medical institutions. It serves drug distribution, academic services, medical diagnosis, financial technology, traditional Chinese medicine, digital medical care, professional logistics, and comprehensive equipment. The company was formerly known as Realcan Pharmaceutical Co., Ltd. and changed its name to Realcan Pharmaceutical Group Co., Ltd. in December 2018. Realcan Pharmaceutical Group Co., Ltd. was founded in 2004 and is based in Yantai, China.